An artificial intelligence-based model for prediction of clonal hematopoiesis variants in cell-free DNA samples
Gustavo Arango-Argoty(AstraZeneca (South Korea)), Etai Jacob(AstraZeneca (United States)), Gerald J. Sun(AstraZeneca (United States)), J. Carl Barrett(National Institute of Environmental Health Sciences), Zhongwu Lai(AstraZeneca (United States)), Elizabeth Choe(Allen Institute), Aleksandra Markovets(AstraZeneca (United States)), Marzieh Haghighi(Broad Institute)
Cited by 8
Related Papers
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
|Nature Medicine|2015|1.5k
DeepARG: a deep learning approach for predicting antibiotic resistance genes from metagenomic data
|Microbiome|2018|962
Nucleus segmentation across imaging experiments: the 2018 Data Science Bowl
|Nature Methods|2019|852
Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2016|843